PCYN · Procyon Corp
Market Cap
$2.03M
Shares
8.12M
PCYN metrics
45 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$0.25
Market cap
$2.03M
Price action
19 metricsPrice change (1W)
+0.0%
Price change (30D)
+0.0%
Price change (3M)
+24.4%
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
+145.1%
Trailing year
Price change (5Y)
-36.2%
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
—
Beta
—
RSI (14D)
59.4
Price vs SMA 50
+24.8%
Price vs SMA 200
-9.7%
Avg volume (3M)
—
Relative volume
—
Average dollar volume
—
Company
3 metricsSector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
8.12M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.4×
reciprocal yield 245.5%
P / book
0.9
reciprocal yield 112.7%
FCF yield
-6.2%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-16.8%
Historical valuation
8 metricsP / E historical average (3Y)
16.9×
reciprocal yield 5.9%
P / E historical average (5Y)
16.9×
reciprocal yield 5.9%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
78.1%
Operating margin
-4.6%
Trailing 12 months
Net margin
-6.8%
Gross profit (TTM)
$3.89M
Operating profit (TTM)
−$231,705
Net income (TTM)
−$341,140
Trailing 12 months
Diluted EPS (TTM)
$-0.04
FCF margin
-2.5%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+17.5%
Year over year
Net income growth YoY
+407.0%
Revenue (TTM)
$4.98M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.3%
Year over year · more shares
Revenue CAGR (3Y)
+1.8%
Revenue CAGR (5Y)
+3.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-14.9%
Return on assets
-10.6%
Debt / equity
—
Current ratio
3.1
EBITDA (TTM)
—
Free cash flow (TTM)
−$125,163
Quick ratio
2.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$121,528
Total assets
$3.20M
Total debt
$33,640
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$61,251
Capital expenditures (TTM)
$63,912
R&D (TTM)
—
SG&A (TTM)
$2.04M
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Short interest
3 metricsShort interest
—
Latest settlement
Days to cover
—
Short-squeeze score
—
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—